(1) Little is known, however, about plasminogen activators in solid tumours of the upper gastrointestinal tract.

(2) The concentrations of urokinase type plasminogen activator in the duodenum resemble the quantities found in normal stomach tissue biopsy specimens.

(3) For urokinase type plasminogen activator antigen in the stomach the opposite was observed.

(4) In summary, several approaches have produced engineered plasminogen activators with an increased thrombolytic potency in experimental animal models.

(5) The tissue type plasminogen activator antigen concentrations in both oesophageal carcinomas and stomach carcinomas were similar to those of the normal tissues.

(6) In the presence of fibrin, tissue type plasminogen activator converts plasminogen to plasmin, which subsequently cleaves the chromogenic substrate.

(7) The significantly lower plasminogen activator activity of malignant ascites is associated with greatly increased concentrations of plasminogen activator inhibitor-1.

(8) And he adds that trace levels of plasminogen would have been present in the products made from the infected donor's blood.

(9) Our results confirm that alcoholic ascites contains plasminogen activating activity.

(10) Murine monoclonal antibodies conjugated with plasminogen activators may be valuable for targeting the therapeutic agent to thrombus.

(11) In the present study tissue type plasminogen activator activity in columnar carcinomas of the stomach, however, was significantly decreased.

(12) Plasminogen activator ( PA ) and plasminogen activator inhibitor ( PAI ) are involved in many physiological or pathological events.

(13) Objective To investigate the plasma tissue-type plasminogen activator(t-PA) and plasminogen activator inhibitor(PAI) in coronary heart disease patients with angina pectoris and its probable mechanism.

(14) NIHSS scores were determined before tissue plasminogen activator bolus and at 60 and 120 minutes in both data sets.

(15) Reteplase is a part of human tissue-type plasminogen . It is expressed in Escherichia Coli cells.

(16) Objective To investigate the relationship between the plasminogen activator inhibitor 1(PAI 1) promotor region gene polymorphism and cerebral stroke.

(17) Improved thrombolytic therapy will most likely consist of potent specific plasminogen activators in combination with targeted anticoagulant and/or antiplatelet agents.

(18) Neither study, however, directly measured the ascitic concentrations of tissue plasminogen activator.

(19) The amount of colour developed during a fixed time is proportional to the tissue type plasminogen activator activity in the sample.

(20) These results could suggest a prominent role of tissue type plasminogen activator in the pathogenesis of endothelin induced gastric mucosal damage.

(21) Fibrinolytic activity was determined by a balance between tissue plasminogen activator and plasminogen activator inhibitor-1.

(22) These results give rise to the hypothesis that endothelin might increase the tissue type plasminogen activator activity accompanying the gastric mucosal injury.

(23) We studied the mechanism of plasma and tissue kallikrein in activating plasminogen.

(24) Objective To construct an expression vector for highly efficient expression of tissue-type plasminogen activator (t-PA) confined in the mammary gland of cow to develop a cow mammary gland bioreactor.

(25) The appearance of serine proteases such as thrombin(), tissue plasminogen activator and plasmin in the CNS have come under increasing scrutiny.

(26) Maybe liver softening-Granules treated hepatic fibrosis by regulating the plasminogen activator system and hasten the fibrin dissolve.

(27) Recently, a lot of studies have been demonstrated that SPC increased cell migration and induced the expression of plasminogen activator related to cell migration.

(28) Lysis of the hematoma with various enzymes, such as urokinase or tissue plasminogen activator (TPA), and drainage of liquefied clot has become an alternative.

(29) But Dr. Marian LaMonte, co-director of the Brain Attack Team, began intravenously administering a drug called tissue plasminogen activator (t-PA).

(30) Objective To investigate effects of two proinflammatory cytokines on the production of plasminogen activator inhibitor 1(PAI 1) by human pleural mesothelial cells(HPMC).

(31) We measured the plasminogen(PLG)content and plasmin(PL)activity in 54 leukemic patients.

(32) PURPOSE : To establish a stable cell strain secreted recombinant tissue - type plasminogen activator ( rt - PA ).

(33) Recombinant tissue-type plasminogen activator (r-TPA) was also used when clinically indicated.

(34) This review will focus on approved agents and the clinical trials that have led to their widespread use, including streptokinase, urokinase, recombinant tissue-type plasminogen activator.

(35) Plasma levels of prekallikrein (PK), plasminogen (PLG), fibrinogen (FIG) in 84 cases of malignant tumor were studied with an advanced method. Each item was measured 100 times.

(36) Objective To investigate the anticoagulative and fibrinolytic effects of lumbrokinase and their relation to tissue plasminogen activator (t-PA).

(37) The properties, determination of plasmin plus plasminogen and the effect on cheese and UHT milk are introduced in this paper.

(38) Objective: To evaluate the efficacy and safety of recombinant tissue plasminogen activator in hyper acute cerebral infarction.

(39) Objective To monitor the dynamic changes of tissue type plasminogen activator(t-PA) and plasminogen activator inhibitor-I(PAI-I) activity after and before PTCA in patients with ACS.

(40) This was accompanied by severe disruption of the blood–brain barrier and an increased rate of intracerebral hemorrhages after tissue plasminogen activator treatment.

(41) AIM: To observe the effect of extract of Ginkgo biloba leaves on plasminogen activator inhibitor 1(PAI-1)and thromboxane B2(TXB-2)in type 2 diabetes mellitus(DM).

(42) In this process, urokinase - type plasminogen activator ( uPA ) and P - selectin play a very important role.

(43) Objective: To identify of urokinase - type plasminogen activator ( UPA ) expression in patients with epithelial ovarian carcinoma.

(44) Intravenous administration of recombinant tissue plasminogen activator remains the most beneficial proven intervention for emergency treatment of stroke.

(45) Objective To explore the relationship between the activity change of tissue type plasminogen activator(TPA) of retinas and retinal edema in retinal ischemia and reperfusion rats.

(46) Should the patients with middlecerebralarteryocclusion of transient ischemic attack be treated with intravenous tissue plasminogen activator?

(47) Plasmin and plasminogen is a major pair of alkaline proteinase in milk, which affects dairy products by hydrolyzing milk proteins.

(48) Refer to the fibrin plate assay and the clot lysis assay for determining the activities of streptokinase and urokinase, we established an assay for the activity determination of plasminogen.

(49) The high-phenol group also experienced a greater drop in the activity of another clot promoter, plasminogen activator inhibitor-1.

(50) Objective To observe the effect of recombinant tissue plasminogen activator in the treatment of acute myocardial infarction.

(51) Objective:To examine whether VLDL or LDL can stimulate the secretion of plasminogen activator inhibitor type 1 (PAI-1) in hepatic cells.

(52) The von Willebrand's disease factors in plasm, adjusted protein of thrombase and inhibitor 1 of activator of plasminogen were detected with enzyme-linked immunosorbent assay.

(52) is a sentence dictionary, on which you can find good sentences for a large number of words.

(53) The thrombolytic effect was compared between urokinase (UK) and human tissue plasminogen activator (t-PA) in rabbits with experimental iliofemoral artery thrombus.

(54) According to reports, Nattokinase has plasmin-like bio-characteristic that lyses fibrin directly, or increases activity of pro-urokinase and t-PA (Tissue Plasminogen Activator).

(55) The plasminogen activator (PA) system, which controls the formation and activity of plasmin, plays a key role in modulating hemostasis, thrombosis, and several other biological processes.

(56) Objective To study the changes of the endothelial tissue plasminogen activator reserve capacity in patients with acute coronary syndromes.

(57) Objective To explore the relationship between plasminogen activator inhibitor type-1 (PAI-1)and its biological behaviour of hepatocellular carcinoma (HCC).

(58) Objective: To identify the significance of urokinase-type plasminogen activator expression in patients with epithelial ovarian carcinoma.

(59) The screening of human tissue plasminogen activator recombinant plasmid showed that the two methods can recognize the positive colones quickly and correctly.